'Public health services act' diaporamas de présentation

Course Objective

Development and Approval of Drugs and Devices EPI260 Lecture 1: Overview March 31, 2011 Richard Chin, M.D. Course Objective. Provide a survey of drug and device development from late preclinical through Phase 3 clinical studies. Course Outline. Overview

679 views • 54 slides

FDA Regulation of In Vitro Diagnostic Tests

FDA Regulation of In Vitro Diagnostic Tests. George Washington University March 8, 2011. Katherine Serrano Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health/FDA Katherine.serrano@fda.hhs.gov.

845 views • 38 slides

Overview of Florida Administrative Code 65G-8.001-012

Overview of Florida Administrative Code 65G-8.001-012. Reactive Strategies. Overview of Rule 65G-8. Establishes procedure for approval of crisis intervention curricula Requires providers to establish policy and procedures for the use of reactive strategies

662 views • 32 slides

Overview of Florida Administrative Code 65G-8.001-012

Overview of Florida Administrative Code 65G-8.001-012. Reactive Strategies. Overview of Rule 65G-8. Establishes procedure for approval of crisis intervention curricula Requires providers to establish policy and procedures for the use of reactive strategies

485 views • 32 slides

Key Issues Impacting The Future of Biosimilars

Key Issues Impacting The Future of Biosimilars. Foley & Lardner Life Sciences Transactions Conference San Diego September 30, 2009 Michael A. Swit, Esq. Vice President. Standard Disclaimers. Views expressed here are solely mine and do not reflect those of my firm or any of its clients.

491 views • 28 slides

Chapter 24

Chapter 24. Rural and Migrant Populations. Rural Defined . Rural Distribution of people across space Metropolitan area Nonmetropolitan area. Rural Defined . Fewer than 2,500 residents Demographics 28 percent under age 18 30 percent over age 65. Rural Defined.

336 views • 24 slides

July 23, 2013

Proviso 33.34: Hospital and Safety Net Providers Innovation. July 23, 2013. SCORH. Agenda. Proviso 33.34 Teams Proviso 33.34 A(1), C, D Scope Proviso 33.34 overview Reimbursement Methodology Healthy Outcomes Plan (HOP ) Timelines Website. Proviso 33.34 Teams.

290 views • 19 slides

Responsible Conduct in Research

Responsible Conduct in Research. HUMAN SUBJECT PROTECTION. Responsible Conduct of Research.

299 views • 14 slides

Biosimilars 2009 Update Pending Legislation Review

Biosimilars 2009 Update Pending Legislation Review. Pam Politis AIPLA Spring Meeting 2009 May 14, 2009. Follow-on Biologics Bills in the House of Representatives 2009. H.R. 1427 Waxman Bill. H.R. 1545 Eshoo Bill. Pathway for Biosimilars Act Introduced March 17, 2009

210 views • 10 slides

NC HIE Program Legal and Policy Work Group Pre-Meeting Conference Call for New Members

221 views • 9 slides

Conscience, Health Care and the CMA

Conscience, Health Care and the CMA. John Brehany, Ph.D., S.T.L. Catholic Conscience Formation: Truth and Freedom April 20-21, 2012. Introduction. Review status quo on respect for conscience rights, with a focus on trends in medical profession

122 views • 0 slides